TRT and Sleep Apnea: Risk Factors, Screening & Management

Does TRT cause sleep apnea?

TRT does not typically cause new sleep apnea in men without predisposing risk factors, but it can worsen existing obstructive sleep apnea (OSA) or push subclinical cases past the symptomatic threshold. The Endocrine Society's 2018 clinical practice guidelines list “untreated severe obstructive sleep apnea” as a condition to evaluate and treat before starting TRT — reflecting the concern that testosterone may exacerbate breathing-related sleep disturbance.

A 2014 meta-analysis published in the Journal of Clinical Sleep Medicine examined the available data and found a small but statistically significant worsening of the apnea-hypopnea index (AHI) — the measure of how many breathing interruptions occur per hour of sleep — in men receiving testosterone therapy. The effect was most pronounced in men who were already obese, had large neck circumference, or had pre-existing mild OSA.

For lean men with no OSA risk factors, the risk of developing sleep apnea from TRT alone is very low. For men with existing risk factors — particularly obesity (BMI > 30), age over 50, and large neck circumference — the risk is meaningful enough to warrant screening before starting TRT and monitoring during therapy.

How does testosterone affect breathing during sleep?

The mechanism by which testosterone may worsen sleep apnea is not fully established, but several pathways have been proposed based on published research. Understanding these helps explain why not all men are equally affected.

Central respiratory drive

Testosterone may reduce the brain's sensitivity to carbon dioxide (CO2), which is the primary trigger for breathing during sleep. When CO2 sensitivity decreases, the apneic threshold drops — meaning longer pauses in breathing can occur before the brain triggers a compensatory breath. This is a central (brain-mediated) effect, distinct from the airway obstruction that characterizes most OSA.

Upper airway effects

Testosterone may promote fat deposition in the upper airway soft tissues and affect the tone of pharyngeal muscles during sleep. Increased soft tissue mass in the throat narrows the airway, while reduced muscle tone allows the tissue to collapse more easily. This is the same anatomical dynamic that makes obesity the strongest risk factor for OSA regardless of hormone status.

Fluid retention

Testosterone and its aromatized product estradiol both promote fluid retention. Excess extracellular fluid can redistribute to the neck and upper airway in the supine position during sleep, contributing to airway narrowing. This mechanism is particularly relevant in the first few months of TRT when fluid retention is greatest.

Who is at risk for sleep apnea on TRT?

Not all men on TRT face the same sleep apnea risk. The predisposing factors are well-characterized, and they are the same factors that drive OSA in the general population — TRT simply adds an incremental push.

Men with two or more high-risk factors should strongly consider a baseline sleep study before starting TRT. The study provides an objective AHI measurement that can be compared against follow-up testing if symptoms develop during treatment.

What screening should you do before starting TRT?

The Endocrine Society recommends evaluating for sleep apnea symptoms before initiating TRT. This does not mean every man needs a formal sleep study — but every man should be asked about sleep apnea risk factors and symptoms. A structured approach ensures that men at risk are identified before TRT potentially worsens their condition.

Step 1: STOP-BANG questionnaire

The STOP-BANG is a validated 8-question screening tool used widely in clinical practice. Score one point for each “yes”:

• Snoring: Do you snore loudly?
• Tired: Do you feel tired or sleepy during the day?
• Observed: Has anyone observed you stop breathing during sleep?
• Pressure: Do you have or are being treated for high blood pressure?
• BMI: BMI greater than 35?
• Age: Age over 50?
• Neck circumference: Neck circumference greater than 16 inches (40 cm)?
• Gender: Male?

A score of 3 or higher suggests moderate-to-high risk for OSA and warrants a sleep study. Since all TRT patients are male (scoring 1 point automatically), any 2 additional risk factors trigger the recommendation for formal evaluation.

Step 2: Sleep study (when indicated)

A polysomnography (PSG) — either in-lab or a home sleep test (HST) — measures AHI, oxygen saturation, sleep stages, and breathing events. Home sleep tests are adequate for diagnosing OSA in most patients and are significantly cheaper and more convenient than in-lab studies. Your physician can order either based on your risk profile.

AHI scores categorize OSA severity: 5-14 events/hour is mild, 15-30 is moderate, and above 30 is severe. The Endocrine Society's contraindication applies primarily to untreated severeOSA (AHI > 30). Mild-to-moderate OSA that is treated with CPAP is not a contraindication to TRT.

What sleep apnea symptoms should you watch for on TRT?

After starting TRT, monitor for new or worsening sleep symptoms. Because sleep apnea develops gradually, the symptoms can be subtle — especially if you sleep alone and have no one to report snoring or breathing pauses.

• Loud, chronic snoring — especially if it starts or worsens after beginning TRT
• Witnessed breathing pauses — ask your partner if you stop breathing during sleep
• Waking with gasping or choking — a sign of airway obstruction during sleep
• Excessive daytime sleepiness — falling asleep during meetings, while driving, or during passive activities despite adequate time in bed
• Morning headaches — caused by nocturnal hypoxia and CO2 retention
• Unrefreshing sleep — feeling tired despite 7-8 hours in bed
• Nocturia — waking to urinate multiple times per night (sleep apnea increases atrial natriuretic peptide, promoting urine production)
• Worsening mood or cognitive function — despite optimized testosterone and estrogen levels (see our mood changes guide)

If any of these symptoms develop or worsen after starting TRT, report them to your prescribing physician. A sleep study can confirm or rule out OSA. Do not assume fatigue or poor sleep quality is a normal side effect of TRT — untreated sleep apnea directly undermines the benefits of testosterone therapy and carries its own cardiovascular risks.

How do you manage TRT and sleep apnea together?

Men who have both hypogonadism and sleep apnea can benefit from treating both conditions simultaneously. In fact, the combination often produces better outcomes than treating either alone — untreated OSA impairs TRT effectiveness, and untreated hypogonadism contributes to the fatigue and metabolic dysfunction that make OSA worse.

Treatment priority

If newly diagnosed with both conditions, the Endocrine Society recommends treating sleep apnea first. Establishing CPAP compliance before starting TRT ensures the airway is managed before testosterone potentially worsens breathing parameters. In practice, many clinicians start CPAP and TRT concurrently, with close monitoring of sleep symptoms in the first 3 months.

Ongoing management

• Maintain CPAP compliance: Use your CPAP every night, not just most nights. Consistent use prevents the desaturation events that impair TRT benefits.
• Use minimum effective TRT dose: Higher doses produce more fluid retention and greater respiratory drive effects. Keep your dose at the minimum that resolves symptoms.
• Lose weight if applicable: Weight loss is the single most effective intervention for OSA severity. Losing 10% of body weight can reduce AHI by 25-30%. TRT can actually help with this — by improving energy and body composition, it may facilitate the exercise and dietary changes needed for weight loss.
• Recheck sleep study if symptoms change: If daytime sleepiness increases, snoring worsens, or CPAP pressures seem inadequate after starting TRT, get a repeat sleep study. Your optimal CPAP pressure may need adjustment.
• Monitor hematocrit closely: Both sleep apnea (via chronic intermittent hypoxia) and TRT (via erythropoiesis stimulation) independently raise hematocrit. The combination can push hematocrit higher than either condition alone. Track it at every blood draw and follow the management recommendations in our cardiovascular health guide.

Does CPAP affect TRT effectiveness?

CPAP does not interfere with TRT — it enhances it. Untreated sleep apnea causes chronic intermittent hypoxia, elevated cortisol, insulin resistance, and systemic inflammation, all of which blunt the benefits of testosterone therapy. Men who use CPAP consistently report better energy, mood, and body composition outcomes on TRT compared to men with untreated OSA.

There is also a direct hormonal benefit. Treating sleep apnea with CPAP can raise endogenous testosterone by 10-15% in some men, because the nocturnal hypoxia that suppresses the HPG axis is eliminated. For men with borderline hypogonadism, treating OSA alone sometimes raises testosterone enough to defer or avoid TRT entirely — which is why sleep apnea screening is part of a thorough hypogonadism evaluation.

If you are already on TRT and diagnosed with sleep apnea, starting CPAP often produces a noticeable boost in how you feel — not because TRT was not working, but because untreated OSA was undermining the benefits. The combination of adequate testosterone plus uninterrupted, well-oxygenated sleep is greater than the sum of its parts.

How does TRT affect sleep quality overall?

Beyond the sleep apnea concern, TRT generally improves sleep quality in hypogonadal men. Low testosterone is associated with disrupted sleep architecture — less time in deep (slow-wave) sleep and REM sleep, more nighttime awakenings, and increased sleep fragmentation. Restoring testosterone to normal levels often improves these parameters.

The Testosterone Trials found that testosterone treatment improved self-reported sleep quality and reduced daytime sleepiness compared to placebo. Other studies have shown improvements in sleep efficiency (the percentage of time in bed actually spent asleep) and reductions in nighttime waking.

However, the sleep-improving effects of TRT are most pronounced when sleep apnea is either absent or properly treated. Giving testosterone to a man with untreated severe OSA may worsen the OSA enough to negate the sleep quality benefits of normalized testosterone. This is why screening matters — treat the airway, then optimize the hormones.

For the complete side effects picture including how sleep apnea interacts with cardiovascular risk and mood, return to our TRT side effects overview. Hematocrit management for men with both OSA and TRT is covered in our cardiovascular health guide.